Similarly, in human esophageal and breast carcinomas, the deletion of PERK caused cell cycle arrest at the G2/M phase due to reduced Nrf2 activity and the accumulation of ROS, which subsequently led to DNA damage and activated the cell cycle checkpoint [246]. Here, EIF2AK3 is linked to breast carcinoma.